BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
15 results:

  • 1. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
    Li T; Tang Z; Li S; Lu M
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the socs1/JAK2/STAT3 signaling pathway.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; He P; Zeng M
    Exp Mol Med; 2023 Apr; 55(4):831-843. PubMed ID: 37009803
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma.
    Jiang R; He S; Gong H; Wang Y; Wei W; Chen J; Hu J; Ye C; LiuHuang S; Jin S; Wei H; Xu W; Xiao J
    Oxid Med Cell Longev; 2022; 2022():8441676. PubMed ID: 36254233
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outstanding prognostic value of novel ferroptosis-related genes in chemoresistance osteosarcoma patients.
    Zhao J; Zhao Y; Ma X; Feng H; Jia L
    Sci Rep; 2022 Mar; 12(1):5029. PubMed ID: 35322804
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.
    Tolosa EJ; Fernandez-Barrena MG; Iguchi E; McCleary-Wheeler AL; Carr RM; Almada LL; Flores LF; Vera RE; Alfonse GW; Marks DL; Hogenson TL; Vrabel AM; Horn IP; Koenig AN; Safgren SL; Sigafoos AN; Erkan M; Romecin-Duran PA; Sarabia Gonzalez A; Zhou B; Javelaud D; Marsaud V; Graham RP; Mauviel A; Elsawa SF; Fernandez-Zapico ME
    Biochem J; 2020 Sep; 477(17):3131-3145. PubMed ID: 32766732
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MicroRNA-29a suppresses the invasion and migration of osteosarcoma cells by regulating the socs1/NF-κB signalling pathway through negatively targeting DNMT3B.
    Gong HL; Tao Y; Mao XZ; Song DY; You D; Ni JD
    Int J Mol Med; 2019 Oct; 44(4):1219-1232. PubMed ID: 31364725
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effect of socs1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
    Yu SJ; Long ZW
    Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype.
    Karpinski P; Myszka A; Ramsey D; Kielan W; Sasiadek MM
    Tumour Biol; 2011 Aug; 32(4):653-9. PubMed ID: 21625944
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
    Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
    J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
    Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
    J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/jab1 correlates with differentiation of embryonal rhabdomyosarcoma.
    Tsuchida R; Miyauchi J; Shen L; Takagi M; Tsunematsu Y; Saeki M; Honna T; Yamada S; Teraoka H; Kato JY; Mizutani S
    Jpn J Cancer Res; 2002 Sep; 93(9):1000-6. PubMed ID: 12359053
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma.
    Leavey PJ; Mantadakis E; Maale G
    Pediatr Hematol Oncol; 2002; 19(7):483-9. PubMed ID: 12217194
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
    Goorin A; Strother D; Poplack D; Letvak LA; George M; Link M
    Med Pediatr Oncol; 1995 Jun; 24(6):362-7. PubMed ID: 7715542
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.